Braza, Mounia S <br/><br/>
Anti-tumour immunotherapy with Vγ9Vδ2 T lymphocytes: from the bench to the bedside.  [electronic resource] 

 -  British journal of haematology  Jan 2013 
 - 123-32 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1365-2141 
<br/><br/><label>Standard No.: </label>10.1111/bjh.12090  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adaptive Immunity<br/>Adjuvants, Immunologic--pharmacology<br/>Antigens, Neoplasm--immunology<br/>CD8-Positive T-Lymphocytes--immunology<br/>Cells, Cultured--drug effects<br/>Clinical Trials as Topic<br/>Dendritic Cells--immunology<br/>Diphosphonates--pharmacology<br/>Gene Rearrangement, delta-Chain T-Cell Antigen Receptor<br/>Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor<br/>Humans<br/>Immunity, Innate<br/>Immunologic Surveillance--immunology<br/>Immunotherapy, Adoptive<br/>Killer Cells, Natural--immunology<br/>Mesenchymal Stem Cells--immunology<br/>Neoplasms--immunology<br/>Receptors, Antigen, T-Cell, alpha-beta--analysis<br/>Receptors, Antigen, T-Cell, gamma-delta--analysis<br/>T-Lymphocyte Subsets--chemistry<br/>T-Lymphocytes, Cytotoxic--chemistry<br/>T-Lymphocytes, Regulatory--immunology<br/>Translational Research, Biomedical<br/>Tumor Escape--immunology